Background: The physiological roles of eosinophils that accumulate in the uterus during pregnancy and of uterus-dwelling mast cells remain unknown. In the present study, we investigated the degranulation of eosinophils and mast cells within the normal course of pregnancy and after delivery by measuring the urinary concentrations of eosinophil-derived neurotoxin (EDN) and N-methylhistamine. Methods: Spot urine samples from 65 pregnant women and 15 nonpregnant, age-matched women were examined. Urinary EDN and N-methylhistamine concentrations were measured by radioimmunoassay and standardized with urinary creatinine concentration. Results: A significant increase in the urinary EDN concentration was observed until the second trimester in the normal pregnancies. The elevated urinary EDN levels decreased after the onset of labor in the third trimester and normalized within 1 month after normal vaginal delivery. In women who underwent a cesarean section, the urinary EDN concentration was significantly higher for up to 1 month after delivery, compared to that in women who underwent a vaginal delivery. In contrast, the urinary N-methylhistamine concentration did not change until the second trimester and was significantly decreased during the third trimester. No significant correlation between the peripheral blood eosinophil count and the urinary EDN concentration was observed in these subjects. Conclusions: Eosinophils appear to play a role in the progression of pregnancy and recovery after a cesarean section through the degranulation of eosinophils. In addition, mast cell degranulation does not appear to be related to the contraction of uterine smooth muscle during labor.

Keywords:
Eosinophil, Degranulation, Mast cell, Eosinophil-derived neurotoxin, N-methylhistamine, Cesarean section
1.
Gleich GJ: Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651–663.
2.
Wardlaw AJ, Moqbel R, Kay AB: Eosinophils: Biology and role in disease. Adv Immunol 1995;60:151–266.
3.
Gleich GJ, Adolphson CR, Leiferman KM: The biology of the eosinophilic leukocyte. Annu Rev Med 1993;44:85–101.
4.
Bochner BS: Road signs guiding leukocytes along the inflammation superhighway. J Allergy Clin Immunol 2000;106:817–828.
5.
O’Sullivan S, Roquet A, Dahlen B, Dahlen S, Kumlin M: Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy 1998;28:1332–1339.
6.
Gouon-Evans V, Rothenberg ME, Pollard JW: Postnatal mammary gland development requires macrophages and eosinophils. Development 2000;127:2269–2282.
7.
Lucey DR, Nicholson-Weller A, Weller PF: Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci USA 1989;86:1348–1351.
8.
Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF: Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000;105:945–953.
9.
Domachowske JB, Bonville CA, Dyer KD, Rosenberg HF: Evolution of antiviral activity in the ribonuclease A gene superfamily: Evidence for a specific interaction between eosinophil-derived neurotoxin (EDN/RNase 2) and respiratory syncytial virus. Nucleic Acids Res 1998;26:5327–5332.
10.
Domachowske JB, Dyer KD, Adams AG, Leto TL, Rosenberg HF: Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res 1998;26:3358–3363.
11.
Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg ME: Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 1999;103:1719–1727.
12.
Katayama H, Yokoyama A, Kohno N, Sakai K, Hiwada K, Yamada H, Hirai K: Production of eosinophilic chemokines by normal pleural mesothelial cells. Am J Respir Cell Mol Biol 2002;26:398–403.
13.
Malek J, Kobilkova J, Cech E, Kuzel D: Vaginal cytologic patterns during the biological preparation for labor. Acta Cytol 1967;11:444–448.
14.
Ross R, Klebanoff SJ: The eosinophilic leukocyte. Fine structure studies of changes in the uterus during the estrous cycle. J Exp Med 1966;124:653–660.
15.
Gouon-Evans V, Pollard JW: Eotaxin is required for eosinophil homing into the stroma of the pubertal and cycling uterus. Endocrinology 2001;142:4515–4521.
16.
Wasmoen TL, Coulam CB, Leiferman KM, Gleich GJ: Increases of plasma eosinophil major basic protein levels late in pregnancy predict onset of labor. Proc Natl Acad Sci USA 1987;84:3029–3032.
17.
Wagner JM, Bartemes K, Vernof KK, Dunnette S, Offord KP, Checkel JL, Gleich GJ: Analysis of pregnancy-associated major basic protein levels throughout gestation. Placenta 1993;14:671–681.
18.
Guo CB, Kagey-Sobotka A, Lichtenstein LM, Bochner BS: Immunophenotyping and functional analysis of purified human uterine mast cells. Blood 1992;79:708–712.
19.
Massey WA, Guo CB, Dvorak AM, Hubbard WC, Bhagavan BS, Cohan VL, Warner JA, Kagey-Sobotka A, Lichtenstein LM: Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology. J Immunol 1991;147:1621–1627.
20.
Granerus G, Gillbrand B, Wetterqvist H: Histamine metabolism in normal pregnancy and in toxaemia of pregnancy. Acta Obstet Gynecol Scand 1977;56:81–86.
21.
Matsumoto K, Saito H: The role of eosinophils in asthma: Sarastro or the Queen of the Night? Int Arch Allergy Immunol 2001;125:290–296.
22.
Tischendorf FW, Brattig NW, Lintzel M, Buttner DW, Burchard GD, Bork K, Muller M: Eosinophil granule proteins in serum and urine of patients with helminth infections and atopic dermatitis. Trop Med Int Health 2000;5:898–905.
23.
Cottin V, Deviller P, Tardy F, Cordier JF: Urinary eosinophil-derived neurotoxin/protein X: A simple method for assessing eosinophil degranulation in vivo. J Allergy Clin Immunol 1998;101:116–123.
24.
Khalil Kalaajieh W, Hoilat R: Asthma attack severity and urinary concentration of Eosinophil X protein in children. Allergol Immunopathol (Madr) 2002;30:225–231.
25.
Pucci N, Lombardi E, Novembre E, Farina S, Bernardini R, Rossi E, Favilli T, Vierucci A: Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity. J Allergy Clin Immunol 2000;105:353–357.
26.
Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993;14:353–356.
27.
Strom TB, Roy-Chaudhury P, Manfro R, Zheng XX, Nickerson PW, Wood K, Bushell A: The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996;8:688–693.
28.
Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T: Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999;117:550–555.
29.
Saito S, Tsuda H, Michimata T: Prostaglandin D2 and reproduction. Am J Reprod Immunol 2002;47:295–302.
30.
Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K: Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001;193:255–261.
31.
Tsuda H, Michimata T, Sakai M, Nagata K, Nakamura M, Saito S: A novel surface molecule of Th2- and Tc2-type cells, CRTH2 expression on human peripheral and decidual CD4+ and CD8+ T cells during the early stage of pregnancy. Clin Exp Immunol 2001;123:105–111.
32.
Gervais FG, Cruz RP, Chateauneuf A, Gale S, Sawyer N, Nantel F, Metters KM, O’Neill G P: Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol 2001;108:982–988.
33.
Zuo J, Lei ZM, Rao CV, Pietrantoni M, Cook VD: Differential cyclooxygenase-1 and -2 gene expression in human myometria from preterm and term deliveries. J Clin Endocrinol Metab 1994;79:894–899.
34.
Xu B, Pekkanen J, Hartikainen AL, Jarvelin MR: Caesarean section and risk of asthma and allergy in adulthood. J Allergy Clin Immunol 2001;107:732–733.
35.
Elovic AE, Ohyama H, Sauty A, McBride J, Tsuji T, Nagai M, Weller PF, Wong DT: IL-4-dependent regulation of TGF-alpha and TGF-beta1 expression in human eosinophils. J Immunol 1998;160:6121–6127.
36.
Yang J, Torio A, Donoff RB, Gallagher GT, Egan R, Weller PF, Wong DT: Depletion of eosinophil infiltration by anti-IL-5 monoclonal antibody (TRFK-5) accelerates open skin wound epithelial closure. Am J Pathol 1997;151:813–819.
37.
Sugimoto Y, Yamasaki A, Segi E, Tsuboi K, Aze Y, Nishimura T, Oida H, Yoshida N, Tanaka T, Katsuyama M, Hasumoto K, Murata T, Hirata M, Ushikubi F, Negishi M, Ichikawa A, Narumiya S: Failure of parturition in mice lacking the prostaglandin F receptor. Science 1997;277:681–683.
38.
Chan CL, Jones RL, Lau HY: Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells. Br J Pharmacol 2000;129:589–597.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.